GlassScriptPhysician profile
Nagendra Natarajan
NPI 1124245618
$2,907.73
in general payments reported to CMS, 2019-2025
22 companies · $66.17 in 2025
The $66.17 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2021: $44.29 · 2022: $41.14 · 2023: $13.12 · 2024: $2,579 · 2025: $66.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,390 · Food and Beverage: $134 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,389.64 |
| Food and Beverage | $134.35 |
| Education | $134.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim International Gmbh | $2,389.64 | 2024 | |
| Advanced Accelerator Applications | $135.41 | 2019 | |
| Aveo Pharmaceuticals, INC. | $134.00 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $88.50 | 2021-2025 | Krazati, Opdualag |
| Abbvie INC. | $49.65 | 2025 | |
| Pfizer INC. | $28.44 | 2022-2023 | |
| Sobi, INC | $16.55 | 2024 | |
| Sirtex Medical INC | $15.22 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $13.68 | 2019 | |
| Genzyme Corporation | $13.22 | 2022 | |
| Gilead Sciences, INC. | $11.92 | 2021 | |
| Epizyme, INC. | $11.50 | 2021 |
10 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nagendra Natarajan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.